Clinical supply management presents a complex web of challenges, from ensuring timely delivery of vital drugs to navigating intricate global regulations. But within this maze lie opportunities to accelerate the path to new treatments.
As the demand for pharmaceuticals grows, concerns about sustainability rise. But, efforts are underway to reconcile the industry’s life-saving mission with environmental, social, and governance responsibilities, as Samsung Biologics’ James Choi explains.